Artificial intelligence (AI) software provider EnvoyAI has launched its EnvoyAI Exchange.
Formerly known as McCoy Medical Technologies, EnvoyAI has 14 signed distribution deals with partner companies, collectively contributing 35 total algorithms to the exchange. There are already three algorithms cleared by the U.S. Food and Drug Administration (FDA) that are available for purchase immediately, as well as more in the European Union. The firm expects FDA 510(k) clearance for others over the next six to 12 months.
Once a hospital has the software installed, any new algorithm can be turned on and integrated into the clinical workflow, the firm said.
